Abstract Program Important Dates to Remember:
January 7, 2019
Abstract submission begins at 12:00 PM CT
March 8, 2019
Abstract submission closes at 5:00 PM CT
May 28, 2019
Corresponding authors notified of submission status
August 16, 2019
Top 5 Junior Member Abstract Program winners notified
Submissions are no longer being accepted to the CAP19 Abstract Program.
Corresponding authors will be sent an e-mail on Tuesday, May 28th regarding the status of their submissions.
Our Abstract Program is a competitive program that promotes a broad range of research in pathology. It offers pathologists and research scientists an opportunity to present original research to their peers in a poster presentation format. Editors from the Archives of Pathology & Laboratory Medicine will evaluate submissions to this program. Additionally, our Abstract Program provides a unique opportunity for residents to enhance their research skills, develop writing proficiency, gain practical experience at presenting their findings, and contribute to the literature and advancement of pathology.
Accepted abstracts and case studies will be published as a web-only supplement to the September 2019 issue of the Archives. CAP junior members who have their abstracts accepted are eligible for cash awards as part of the Top 5 Junior Member Abstract Program.
Abstracts will be evaluated on the following criteria:
- Significance of the hypothesis
- Valid conclusion(s)
- Argument clarity
- Presentation quality
Case studies must include novel findings, such as the following:
- A new disease or condition (i.e. not previously reported).
- A distinctive or unusual presentation of a known disease, with one or more well-documented new findings of special clinical relevance (i.e., potentially applicable to diagnosis, therapy, prognosis, etc.) or that serves to provide new insight into the possible pathogenesis of a disease (hypothesis-generating). The new information might be derived from distinctive morphology and/or ancillary testing.
- A known disease with a demonstrated new finding using state-of-the-art techniques (immunohistochemical, molecular, 3-dimensional reconstruction, cytogenetics, etc.) relevant to a clearly stated hypothesis.
- A known disease presenting with a previously undescribed clinically or etiologically relevant association (i.e., a myelodysplastic syndrome associated with a plasma cell dyscrasia, etc.) in order to heighten awareness of a possible link between entities. Such a link might have been described before in one or more individual case reports, and the addition of a case might help solidify a real association.
Top 5 Junior Member Abstract Program
Authors of the top five accepted abstracts received from CAP junior members will be named as the Top 5 Junior Member Abstract Program award winners and given cash prizes:
- First place cash award = $1,500
- Second place cash award = $1,000
- Third place cash award = $750
- Fourth and fifth place cash awards are $500 each.
- Have performed a substantial portion of the research and work involved in the preparation of the abstract;
- Be listed as either the first or second author;
- Serve as the corresponding author.
Corresponding authors must be available to respond to questions about the content of their submissions from the Archives editorial office, especially during the period of April 8 to May 17, 2019. E-mail addresses for corresponding authors must be active and accessible through August 2019. Corresponding authors will be notified of their submission status on May 28, 2019.
Authors of accepted submissions are expected to prepare a 4 x 8 foot poster summary of their abstract/case study for presentation at CAP19. The poster must be displayed by the authors during CAP19, and authors are expected to be present at their posters during specified Poster Focus times to discuss and answer questions about their research. Specific information regarding Poster Focus times and dates will be included in the acceptance notification e-mail sent to corresponding authors.
If you have questions about the abstract program, please e-mail email@example.com prior to completing your submission. Your questions will be routed to the abstract program coordinator. Please remember that submissions cannot be changed or resubmitted after the March 8 deadline; be sure to carefully review your abstract or case study prior to submitting it.